Bio-Rad Laboratories Change in Accounts Payable 2010-2025 | BIO
- Bio-Rad Laboratories change in accounts payable for the quarter ending March 31, 2025 was $-0.488B, a 12.9% decline year-over-year.
- Bio-Rad Laboratories change in accounts payable for the twelve months ending March 31, 2025 was $-5.162B, a 9.37% decline year-over-year.
- Bio-Rad Laboratories annual change in accounts payable for 2024 was $-2.058B, a 8.14% decline from 2023.
- Bio-Rad Laboratories annual change in accounts payable for 2023 was $-2.241B, a 6.96% decline from 2022.
- Bio-Rad Laboratories annual change in accounts payable for 2022 was $-2.408B, a 13.16% increase from 2021.
Bio-Rad Laboratories Annual Change in Accounts Payable (Millions of US $) |
|
---|---|
2024 | $-2,058 |
2023 | $-2,241 |
2022 | $-2,408 |
2021 | $-2,128 |
2020 | $-1,877 |
2019 | $-1,819 |
2018 | $-1,990 |
2017 | $-1,916 |
2016 | $-1,809 |
2015 | $-1,730 |
2014 | $-1,807 |
2013 | $-1,804 |
2012 | $-1,664 |
2011 | $-1,640 |
2010 | $-1,537 |
2009 | $-1,386 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $6.639B | $2.567B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
Boston Scientific (BSX) | United States | $157.605B | 39.46 |
Stryker (SYK) | United States | $150.214B | 31.41 |
EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
Medtronic (MDT) | Ireland | $110.324B | 15.64 |
Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
Haleon (HLN) | United Kingdom | $46.676B | 26.62 |
ResMed (RMD) | United States | $37.413B | 28.10 |
GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
Agilent Technologies (A) | United States | $33.852B | 22.07 |
Terumo (TRUMY) | Japan | $27.835B | 36.15 |
Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
Insulet (PODD) | United States | $22.033B | 86.49 |
Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
Baxter (BAX) | United States | $15.595B | 11.64 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
Demant (WILYY) | Denmark | $9.110B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
Haemonetics (HAE) | United States | $3.545B | 16.15 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.334B | 27.70 |
ICU Medical (ICUI) | United States | $3.244B | 23.92 |
QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
AtriCure (ATRC) | United States | $1.598B | 0.00 |
AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
Acuren (TIC) | United States | $1.271B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
Neogen (NEOG) | United States | $1.027B | 13.14 |
BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
InMode (INMD) | Israel | $0.897B | 9.04 |
Owens & Minor (OMI) | United States | $0.685B | 5.69 |
CeriBell (CBLL) | United States | $0.683B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
Evolus (EOLS) | United States | $0.589B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
Valneva SE (VALN) | France | $0.494B | 0.00 |
Surmodics (SRDX) | United States | $0.412B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
Quanterix (QTRX) | United States | $0.332B | 0.00 |
SNDL (SNDL) | Canada | $0.323B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
Cerus (CERS) | United States | $0.271B | 0.00 |
ZimVie (ZIMV) | United States | $0.258B | 11.72 |
Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
Brainsway (BWAY) | Israel | $0.250B | 66.10 |
Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
Biote (BTMD) | United States | $0.230B | 6.46 |
OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
Omeros (OMER) | United States | $0.188B | 0.00 |
High Tide (HITI) | Canada | $0.184B | 0.00 |
Organigram Global (OGI) | Canada | $0.181B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
Exagen (XGN) | United States | $0.149B | 0.00 |
Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
Jin Medical (ZJYL) | China | $0.102B | 0.00 |
Fonar (FONR) | United States | $0.092B | 11.90 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.085B | 0.00 |
Apyx Medical (APYX) | United States | $0.082B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
Zynex (ZYXI) | United States | $0.077B | 0.00 |
Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
MacroGenics (MGNX) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Agape ATP (ATPC) | $0.066B | 0.00 | |
ImmuCell (ICCC) | United States | $0.061B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
Nephros (NEPH) | United States | $0.041B | 55.14 |
United-Guardian (UG) | United States | $0.037B | 12.94 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
Safety Shot (SHOT) | United States | $0.023B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Senestech (SNES) | United States | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |